NATICK, Mass. -( Dow Jones)- Boston Scientific Corp. ( BSX) received reimbursement approval from the French government for the company's Taxus Liberte drug-eluting coronary stent system.
http://c.moreover.com/click/here.pl?r468432337
http://c.moreover.com/click/here.pl?r468432337